Neuro42 Company

Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.

Last Funding Type: Series A
Funding Status: Early Stage Venture
Headquarters: Oakland, California, United States
Founded Date: 2020-01-01
Last Funding Date: 2021-07-27
Total Funding: 7800000.0
Investors Number: 4.0
Industry: Neurodegenerative disease diagnosis and treatment